A wearable electrocardiogram ( ECG ) device is to be distributed more widely after the company that developed it , Cardiac Insight , raised an additional $ 5 m in funding . patients displaying “ transient symptoms ” of heart failure wear the Cardeo Solo imaging device for a week , collecting data that doctors will use to instantly diagnosis cardiac failure if they exist . Cardiac Insight , which spun out of the University of Washington in 2008 , also raised $ 4.5 m in April , the same month the Cardeo Solo received FDA approval . Pricing is yet to be announced for the small , disposable device , currently being sold to hospitals and clinics .
A wearable electrocardiogram (ECG) device is to be distributed more widely after the company that developed it, Cardiac Insight, raised an additional $4.5m in funding. Patients displaying “transient symptoms” of heart conditions wear the Cardeo Solo monitoring device for a week, collecting data that doctors can use to instantly diagnosis cardiac anomalies if they exist. Cardiac Insight, which spun out of the University of Washington in 2008, also raised $4.5m in April, the same month the Cardeo Solo received FDA approval. Pricing is yet to be announced for the small, disposable device, currently being sold to hospitals and cardiologists.